Skip to content
  • Saturday, 15 August 2026
  • 3:12 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • MIT Neuroscientists Discover Millions of Silent Synapses in the Adult Brain Unlocking New Potential for Lifelong Learning
Neuroscience & Brain Research

MIT Neuroscientists Discover Millions of Silent Synapses in the Adult Brain Unlocking New Potential for Lifelong Learning

Rifan Muazin May 22, 2026 0

In a landmark study that challenges long-held dogmas in the field of neurology, researchers at the Massachusetts Institute of Technology…

Read More
Neuroscience & Brain Research

MIT Neuroscientists Discover Millions of Silent Synapses in the Adult Brain Providing a Hidden Reserve for Lifelong Learning

Rifan Muazin May 7, 2026 0

In a revelation that fundamentally alters the established understanding of neural architecture, neuroscientists at the Massachusetts Institute of Technology (MIT)…

Read More
Johnson & Johnson Forecasts Accelerated Growth in 2026 Driven by New Psoriasis Treatment, Icotyde, and Robust Pharma PortfolioPfizer Secures Extended Market Exclusivity for Vyndamax, Delaying Generic Competition Until 2031Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid BiopsyPython Project Setup 2026: uv + Ruff + Ty + Polars
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ